Search Results - "Carmino De Souza"

Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial by Kantarjian, Hagop M, Prof, Hochhaus, Andreas, Prof, Saglio, Giuseppe, Prof, De Souza, Carmino, Prof, Flinn, Ian W, MD, Stenke, Leif, MD, Goh, Yeow-Tee, MD, Rosti, Gianantonio, Prof, Nakamae, Hirohisa, MD, Gallagher, Neil J, MD, Hoenekopp, Albert, MD, Blakesley, Rick E, PhD, Larson, Richard A, Prof, Hughes, Timothy P, Prof

“…Summary Background Nilotinib has shown greater efficacy than imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid…”
Get full text

Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease by Alves, Monica, Reinach, Peter Sol, Paula, Jayter Silva, Vellasco e Cruz, Antonio Augusto, Bachette, Leticia, Faustino, Jacqueline, Aranha, Francisco Penteado, Vigorito, Afonso, de Souza, Carmino Antonio, Rocha, Eduardo Melani

“…This study compares signs, symptoms and predictive tools used to diagnose dry eye disease (DED) and ocular surface disorders in six systemic well-defined and…”
Get full text

Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma by Ferro, Daniela P, Falconi, Monica A, Adam, Randall L, Ortega, Manoela M, Lima, Carmen P, de Souza, Carmino A, Lorand-Metze, Irene, Metze, Konradin

“…The use of computerized image analysis for the study of nuclear texture features has provided important prognostic information for several neoplasias. Recently…”
Get full text

Effects of a physiotherapeutic protocol in cardiorespiratory, muscle strength, aerobic capacity and quality of life after hematopoietic stem cell transplantation by Morais, Natalia Igv, Palhares, Luciana Campanatti, Miranda, Eliana Cm, Lima, Carmen Sp, De Souza, Carmino A, Vigorito, Afonso C

“…To analyze the effects of hospital cardiorespiratory physical therapy protocol on the functional capacity and quality of life of patients submitted to…”
Get full text

Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia by BIZZETTO, Renata, BONFIM, Carmen, PASSWEG, Jakob, ANTONIO DE SOUZA CA, Carmino, GLUCKMAN, Eliane, ROCHA, Vanderson, SOCIE, Gérard, LOCATELLI, Franco, CHAN, Kawah, RAMIREZ, Oscar, STEIN, Joel, NABHAN, Samir, MIRANDA, Eliana

“…Allogeneic stem cell transplantation is the only curative option for patients with hereditary bone marrow failure syndromes. Umbilical cord blood is an…”
Get full text

Impact of SNPs/Haplotypes of IL10 and IFNG on the Development of Diffuse Large B-Cell Lymphoma by Zulli, Roberto, de Souza, Victor Hugo, De Souza, Cármino Antonio, Lieber, Sophia Rocha, Marques, Silvia Barbosa Dutra, Guimarães, Fernando, Sell, Ana M., Visentainer, Jeane Eliete Laguila, Cardozo, Daniela Maria, Colli, Cristiane Maria, Marangon, Amanda Vansan, Aranha, Francisco José Penteado

“…The purpose of this study was to assess the influence of single-nucleotide polymorphisms (SNPs) on cytokine genes in the development of diffuse large B-cell…”
Get full text

A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia by Luz Fiusa, Maiara Marx, Costa-Lima, Carolina, de Souza, Gleice Regina, Vigorito, Afonso Celso, Penteado Aranha, Francisco Jose, Lorand-Metze, Irene, Annichino-Bizzacchi, Joyce M, de Souza, Carmino Antonio, De Paula, Erich V

“…Endothelial barrier breakdown is a hallmark of septic shock, and proteins that physiologically regulate endothelial barrier integrity are emerging as promising…”
Get full text

Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience by Ribeiro, Beatriz Felicio, Miranda, Eliana C M, de Albuquerque, Dulcinéia Martins, Delamain, Márcia T, Oliveira-Duarte, Gislaine, Almeida, Maria Helena, Vergílio, Bruna, da Silveira, Rosana Antunes, Oliveira-Duarte, Vagner, Lorand-Metze, Irene, De Souza, Carmino A, Pagnano, Katia B B

“…To evaluate hematological, cytogenetic and molecular responses as well as the overall, progression-free and event-free survivals of chronic myeloid leukemia…”
Get full text

Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study by Alves, Brunna E, Montalvao, Silmara A L, Aranha, Francisco J P, Lorand-Metze, Irene, De Souza, Carmino A, Annichino-Bizzacchi, Joyce M, De Paula, Erich V

“…Septic shock is the most feared complication of chemotherapy-induced febrile neutropenia. So far, there are no robust biomarkers that can stratify patients to…”
Get full text

The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil by Langhi Junior, Dante Mário, Maiolino, Angelo, Chiattone, Carlos S, de Souza, Carmino Antônio, Covas, Dimas Tadeu, Costa, Fernando Ferreira, Guerino-Cunha, Renato L, Pasquini, Ricardo

Get full text

Patients' perceptions about diagnosis and treatment of chronic myeloid leukemia: a cross-sectional study among Brazilian patients by Hamerschlak, Nelson, Souza, Carmino de, Cornacchioni, Ana Lúcia, Pasquini, Ricardo, Tabak, Daniel, Spector, Nelson, Steagall, Merula

“…Chronic myeloid leukemia (CML) requires strict daily compliance with oral medication and regular blood and bone marrow control tests. The objective was to…”
Get full text

Impairment of thrombin generation in the early phases of the host response of sepsis by Picoli-Quaino, Susan K., BSc, Alves, Brunna E., MD, PhD, Faiotto, Vanessa B., BSc, Montalvao, Silmara A.L., BSc, De Souza, Carmino A., MD, PhD, Annichino-Bizzacchi, Joyce M., MD, PhD, De Paula, Erich V., MD, PhD

“…Abstract Purpose The purpose was to investigate the presence of hypercoagulability in the very early phase of the host response to an infection in the clinical…”
Get full text

Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial by APPERLEY, Jane F, CORTES, Jorge E, DE SOUZA, Carmino A, LARSON, Richard A, LIPTON, Jeffrey H, KHOURY, H. Jean, KIM, Hyeoung-Joon, SILLABER, Christian, HUGHES, Timothy P, ERBEN, Philipp, VAN TORNOUT, Jan, STONE, Richard M, KIM, Dong-Wook, ROY, Lydia, ROBOZ, Gail J, ROSTI, Gianantonio, BULLORSKY, Eduardo O, ABRUZZESE, Elisabetta, HOCHHAUS, Andreas, HEIM, Dominik

“…PURPOSE Patients with chronic myelogenous leukemia in accelerated phase (CML-AP) that is resistant or intolerant to imatinib have limited therapeutic options…”
Get full text

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria by DE LATOUR, Régis Peffault, SCHREZENMEIER, Hubert, DE GUIBERT, Sophie, MARSH, Judith C, PASSWEG, Jakob, MARY, Jean Yves, SOCIE, Gerard, BACIGALUPO, Andrea, BLAISE, Didier, DE SOUZA, Carmino A, VIGOUROUX, Stephane, WILLEMZE, Roelf, TERRIOU, Louis, TICHELLI, Andre, MOHTY, Mohamad

“…In the era of eculizumab, identifying patients with paroxysmal nocturnal hemoglobinuria who may benefit from allogeneic stem cell transplantation is…”
Get full text

How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation by Perini, Guilherme Fleury, Fischer, Thais, Gaiolla, Rafael Dezen, Rocha, Talita Bueno, Bellesso, Marcelo, Teixeira, Larissa Lane Cardoso, Delamain, Marcia Torresan, Scheliga, Adriana Alves de Souza, Ribeiro, Glaciano Nogueira, Neto, Jorge Vaz, Baiocchi, Otávio Cesar Carvalho Guimaraes, Abdo, André Neder Ramires, Arrais-Rodrigues, Celso, Fogliatto, Laura M, Bigni, Ricardo de Sá, Schaffel, Rony, Biasoli, Irene, Pereira, Juliana, Nabhan, Samir Kanaan, Souza, Cármino Antônio de, Chiattone, Carlos Sérgio

“…The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for…”
Get full text

The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest by de Souza, Carmino Antonio, Rego, Eduardo Magalhães, Ribeiro, Glaciano Nogueira, Magalhães, Silvia Maria Meira, da Silva, Celso Arrais Rodrigues, Passos, Leny Nascimento da Motta, Covas, Dimas Tadeu, Tavares, Renato Sampaio, Hungria, Vania T de Moraes, Crusoé, Edvan de Queiroz, Marques, Jr, José Francisco Comenalli, Chiattone, Carlos Sérgio, Langhi, Junior, Dante, Neto, Jorge Vaz Pinto, Laforga, Violete Petitto, Maiolino, Angelo

Get full text

Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project by Fox, Christopher P, Civallero, Monica, Ko, Young-Hyeh, Manni, Martina, Skrypets, Tetiana, Pileri, Stefano, Kim, Seok Jin, Cabrera, Maria Elena, Shustov, Andrei R, Chiattone, Carlos S, Horwitz, Steven M, Dlouhy, Ivan, Spina, Michele, Hitz, Felicitas, Montoto, Silvia, Nagler, Arnon, Martinez, Virginia, De Souza, Carmino A, Fernandez-Alvarez, Ruben, Ballova, Veronika, Gabús, Raul, Inghirami, Giorgio, Federico, Massimo, Kim, Won Seog

“…Extranodal natural killer (NK) T-cell lymphoma (ENKTL) is a unique clinicopathological entity, typically associated with poor survival outcomes. Most published…”
Get full text

Transplant in Diffuse Large B-Cell Lymphoma by Duffles, Guilherme, Souza, Carmino De

“…Diffuse large B-cell lymphoma is the most common type of aggressive lymphoma. Patients that don’t respond to first-line therapy have a poor prognosis. Bone…”
Get full text

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase by Guilhot, Francois, Apperley, Jane, Kim, Dong-Wook, Bullorsky, Eduardo O., Baccarani, Michele, Roboz, Gail J., Amadori, Sergio, de Souza, Carmino A., Lipton, Jeffrey H., Hochhaus, Andreas, Heim, Dominik, Larson, Richard A., Branford, Susan, Muller, Martin C., Agarwal, Prasheen, Gollerkeri, Ashwin, Talpaz, Moshe

“…Treatment options are limited for patients with imatinib-resistant or -intolerant accelerated phase chronic myeloid leukemia (CML-AP). Dasatinib is a novel,…”
Get full text

Head-to-head comparison between 68Ga-PSMA and 18F-FDG-PET/CT in lymphomas: a preliminary analysis by de Souza, Stephan Pinheiro Macedo, Tobar, Natalia, Frasson, Fernanda, Perini, Efrain Araujo, de Souza, Carmino A., Delamain, Marcia T., Ramos, Celso Dario

“…Isolated case reports mention the uptake of radiolabeled PSMA in lymphoma. However, it is not clear if the intensity of 68Ga-PSMA expression varies among…”
Get full text